Olof Ulf Stefan Björklund
Director/Miembro de la Junta en ProNoxis AB .
Perfil
Olof Ulf Stefan Björklund currently works at ProNoxis AB, as Director and Swedish Pharmaceutical Society, as Principal.
Mr. Björklund also formerly worked at OxyPharma AB, as Chief Executive Officer, Annexin Pharmaceuticals AB, as Director, Pharmacia AB, as Head-Clinical Operations, and Aprea Therapeutics AB, as Chief Operating Officer.
Mr. Björklund received his graduate degree from the University of Uppsala.
Cargos activos de Olof Ulf Stefan Björklund
| Empresas | Cargo | Inicio |
|---|---|---|
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Director/Miembro de la Junta | - |
| Swedish Pharmaceutical Society | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Olof Ulf Stefan Björklund.
| Empresas | Cargo | Fin |
|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Director/Miembro de la Junta | - |
| OxyPharma AB | Presidente | - |
| Pharmacia AB | Corporate Officer/Principal | - |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Director Ejecutivo | 20/10/2014 |
Formación de Olof Ulf Stefan Björklund.
| University of Uppsala | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Empresas privadas | 5 |
|---|---|
| Pharmacia AB | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
| OxyPharma AB | |
| Swedish Pharmaceutical Society |
- Bolsa de valores
- Insiders
- Olof Ulf Stefan Björklund
